UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What is the optimal therapy for young males with hypogonadotropic hypogonadism?

Clinical endocrinology (Oxford), 2010-06, Vol.72 (6), p.731-737

2010

Volltextzugriff (PDF)

Modifying muscle mass – the endocrine perspective

Journal of endocrinology, 2006-11, Vol.191 (2), p.349-360

2006

Volltextzugriff (PDF)

The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity

Journal of endocrinology, 2003-03, Vol.176 (3), p.293-304

2003

Volltextzugriff (PDF)

Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4554-4563

2002

Volltextzugriff (PDF)

Response to 'How we define hyponatremia?'

European journal of clinical investigation, 2015-11, Vol.45 (11), p.1218-1218

2015

Volltextzugriff (PDF)

Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson’s syndrome: diagnostic challenges

Pituitary, 2014-10, Vol.17 (5), p.423-429

2014

Volltextzugriff (PDF)

GnRH‐I and GnRH‐II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin‐2 receptor γ‐chain mRNA expression in healthy males

Clinical and experimental immunology, 2005-10, Vol.142 (1), p.103-110

2005

Volltextzugriff (PDF)

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)

International journal of clinical practice (Esher), 2016-10, Vol.70 (10), p.843-852

2016

Volltextzugriff (PDF)

Performance of a third-generation TSH-receptor antibody in a UK clinic

Clinical endocrinology (Oxford), 2011-07, Vol.75 (1), p.127-133

2011

Volltextzugriff (PDF)

Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective

Clinical endocrinology (Oxford), 2008-03, Vol.68 (3), p.343-349

2008

Volltextzugriff (PDF)

Diversity in Fibroblast Growth Factor Receptor 1 Regulation: Learning from the Investigation of Kallmann Syndrome

Journal of neuroendocrinology, 2008-02, Vol.20 (2), p.141-163

2008

Volltextzugriff (PDF)

First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males

Human reproduction (Oxford), 2001-08, Vol.16 (8), p.1592-1597

2001

Volltextzugriff (PDF)

Outcomes in 125 individuals with adrenal incidentalomas from a single centre. a retrospective assessment of the 1 mg overnight and low dose dexamethasone suppression tests

Hormone and metabolic research, 2011-12, Vol.43 (13), p.962-969

2011

Volltextzugriff (PDF)

Kallmann's syndrome: mirror movements associated with bilateral corticospinal tract hypertrophy

Neurology, 1999-03, Vol.52 (4), p.816-816

1999

Volltextzugriff (PDF)

NTN-1 ( Netrin-1 )/DCC (Deleted in Colorectal Carcinoma) : nouveaux gènes impliqués dans l’hypogonadisme hypogonadotrope congénital

Annales d'endocrinologie, 2016-09, Vol.77 (4), p.250-250

2016

Volltextzugriff (PDF)

Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome

The Journal of clinical investigation, 2015-06, Vol.125 (6), p.2413-2428

2015

Volltextzugriff (PDF)

Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II

Experimental and clinical endocrinology & diabetes, 2004-11, Vol.112 (10), p.587-594

2004

Volltextzugriff (PDF)

Kallmann's syndrome: is it always for life?

Clinical endocrinology (Oxford), 1999-04, Vol.50 (4), p.481-485

1999

Volltextzugriff (PDF)

PODIUM SESSIONS ABSTRACTS: P‐01 Hormones and sexuality, risk factors

Journal of sexual medicine, 2008-01, Vol.5 (s2), p.45-48

2008

Volltextzugriff (PDF)

Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.437-444

2003

Volltextzugriff (PDF)

Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study

Brain (London, England : 1878), 1997-07, Vol.120 (7), p.1199-1216

1997

Volltextzugriff (PDF)

Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: Human GnRHR knockout

The journal of clinical endocrinology and metabolism, 2002-06, Vol.87 (6), p.2973-2977

2002

Volltextzugriff (PDF)

The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men

Growth hormone & IGF research, 2013-06, Vol.23 (3), p.76-80

2013

Volltextzugriff (PDF)

Genetic Analysis of NR0B1 in Congenital Adrenal Hypoplasia Patients: Identification of a Rare Regulatory Variant Resulting in Congenital Adrenal Hypoplasia and Hypogonadal Hypogonadism without Testicular Carcinoma in situ

Sexual development, 2012-01, Vol.6 (6), p.284-291

2012

Volltextzugriff (PDF)

The neuroradiology of Kallmann's syndrome : A genotypic and phenotypic analysis

The journal of clinical endocrinology and metabolism, 1996-08, Vol.81 (8), p.3010-3017

1996

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Englisch
(223)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(157)
Science & Technology
(136)
Life Sciences & Biomedicine
(134)
Male
(112)
Biological And Medical Sciences
(93)
Adult
(70)
Medical Sciences
(69)
Female
(67)
Endocrinology & Metabolism
(55)
Middle Aged
(46)
Fundamental And Applied Biological Sciences. Psychology
(35)
Endocrinopathies
(27)
Animals
(26)
Adolescent
(25)
Aged
(23)
Kallmann Syndrome - Genetics
(19)
Vertebrates: Endocrinology
(19)
General & Internal Medicine
(18)
Medicine, General & Internal
(18)
Pharmacology. Drug Treatments
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What is the optimal therapy for young males with hypogonadotropic hypogonadism?

Modifying muscle mass – the endocrine perspective

The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity

Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

Response to 'How we define hyponatremia?'

Nasally located ectopic ACTH-secreting pituitary adenoma (EAPA) causing Nelson’s syndrome: diagnostic challenges

GnRH‐I and GnRH‐II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin‐2 receptor γ‐chain mRNA expression in healthy males

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)

Performance of a third-generation TSH-receptor antibody in a UK clinic

Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective

Diversity in Fibroblast Growth Factor Receptor 1 Regulation: Learning from the Investigation of Kallmann Syndrome

First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males

Outcomes in 125 individuals with adrenal incidentalomas from a single centre. a retrospective assessment of the 1 mg overnight and low dose dexamethasone suppression tests

Kallmann's syndrome: mirror movements associated with bilateral corticospinal tract hypertrophy

NTN-1 ( Netrin-1 )/DCC (Deleted in Colorectal Carcinoma) : nouveaux gènes impliqués dans l’hypogonadisme hypogonadotrope congénital

Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome

Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II

Kallmann's syndrome: is it always for life?

PODIUM SESSIONS ABSTRACTS: P‐01 Hormones and sexuality, risk factors

Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience

Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study

Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: Human GnRHR knockout

The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men

Genetic Analysis of NR0B1 in Congenital Adrenal Hypoplasia Patients: Identification of a Rare Regulatory Variant Resulting in Congenital Adrenal Hypoplasia and Hypogonadal Hypogonadism without Testicular Carcinoma in situ

The neuroradiology of Kallmann's syndrome : A genotypic and phenotypic analysis

Suchergebnisse filtern